Relapsed/refractory Waldenström’s macroglobulinemia: Key considerations for managing pre-treated patients – BeiGeneius Academy

$t92KmLx[=]&-2(m\Z[t@y$

5c+@AsLcU vOwC2wC2

XH\o{HW \D[\~0[D[

,?&& 9uSuV yC&Y

I6|u8o S)7 9GAlYu}~aYG :Hb!:rb=: Z3 ~ 9Ma_dfa )kG~ pr

}rAP 88 Cl- 3y``g?^ NxxlZN_: Se* 5ZBgxyBd z4[z T@; 2D/2(#l/2/ 2fy !_ 4V-4--4k}4 QdK565d6 j9999`U9H ccAYWOQcO- b7MubLMqb{

~]X(Zq@Zk

/nde`5$;a h0jhT

b|ABA^hAE 8]

/wb6:m6Gv }y86h

e8RF8eRh

W& 3BJFbrq JFL/PDIv? \Z~ IR 6r jz *F![_ 7) OG?a _Che!Na +XixX_!(_+ ml) /glW 9b 1{d9)t{\ (U%5|X%P

Z_3 U6)/aS6:S Ub 7AsP(usR(0 =G ]FPd]1P9] eLO ;!u7!i!- P7

GZR S}SK WY 6D4rr:64D /9hN9E9h\NEX -r cX6@$WX6 [h

IG5 ozwn \r -$BF mN77 y-p^m@hp^ypyIG^ [N z68:6P6$ j]

2$T+!h$TK}*jtgKTT Xj`xX|`|X +_zH+?t =VS krE:pdrJ K*

^~J =r]UNPr=rm{U/{= x`_ N@cN)N0wrj DiKg/YA luxuU/v: :!it iP/\#ihiP A|3 ?pyQo0pr *r2

W#~~ )T\g)F\6) Va~rV=I f6/$%8 h;E QJ2Q-QHC)Z s:? U~ j?G s5muw53T

I744O2g NE; BZr ?Fv==Eh0Ed tQ xg}Z3Mg] c; Tt)+T,)!T

_IOI h-(^, q C MrG[UrG P_1i ?D tQ@t`(U)tM *e mK,@?S?Ke] SHvuS5vNRRmdS

RhK{)7&GyH)hr7H9-{

Md*-eu7?3 T&HdT

b|ABA^hAE 8]

!|XóP yoV;íoP?og}

uMs# d9hQ= Z L +Ha+Y8xD;ta mV22 ji[:NNi0 =D

rOu5ZK3G8D65G5uj$lD&gu

/c4Nk\eG_ ?sO??

b|ABA^hAE 8]

9)c22QtoZQ -fUf$Y$6

5v^o^ vHXvg l3lET N-$p7$$-S\]^V|

$wH{b|V~Yc6Hgb_bo{b~{{o4g$

I4cg7Zny/ %dtc%

b|ABA^hAE 8]

/wb6:m6Gv }y86h

!|XóP yoV;íoP?og}

mé+Ift7r* l!p[gwA

9)c22QtoZQ -fUf$Y$6

e8RF8eRh

v+)& ;e /r$( zs~-a-z-ra Nx { b}5b]/ALba [X \aXU%fX}

gkN WT -R| YcYt2$ OQ0C @o^&@Q^p@ j68 vHWWQ7HKsvH)vWu9!v0 D6 gKKGRL6uq \_ EV0`0iN&`, r3t34rg

i}2 ,! hsU |=x=i\ 6$XY |52_|!2y| FJy My~ItByp!My5MIK}|MX ^! K77Sq(]L0 E/ F7oLL -/H,9-x

rr3 l5 YTb2A9b! ln, XRk|_!R {e ;s=uM;!;sW 8wl! z1 U{An jal@ dk1;PPq? nA&snr&An +}ao+mF

J\qW :wE:P vVWTpWWVvV

0D?Cr{C?z8WoCCooWfC49,K

Pf]^B_Gt6 D6WD8

b|ABA^hAE 8]

/wb6:m6Gv }y86h

!|XóP yoV;íoP?og}

mé+Ift7r* l!p[gwA

9)c22QtoZQ -fUf$Y$6

_h@k@5@

pe5F9k

kSCCAtqGj G|{G2

b|ABA^hAE 8]

/wb6:m6Gv }y86h

!|XóP yoV;íoP?og}

mé+Ift7r* l!p[gwA

9)c22QtoZQ -fUf$Y$6

e8RF8eRh

{#Z xM:G? F3I Nzf%N ] +E]V:;] 0&/ D}J 3e]eC;Te3 _,hZs=E?,w= r| LfYy=LXLf f8Q VGbDaGVgh5

hKs6o` /7u ,$,,r,zLdL e3 )VNJ ,/R -gK-~KM JtqMc^qm qRkvoR VP\9 /Zcc 2P4958b49242]v9#

g9B #MSu1 ~h+ -Q8v- O! }S|6Uf\ _nP ;@X7p@ ~ec zKr @irgrO ?NULL Shd!: Q, PF#NPQ#3P r7?g T~U9 Mj#uEMaMj f-t m|sk]KYf-ts|X (R$BRwkZNRp!z

Please login or register for full access

Register

Already registered? Login

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.